Changeflow GovPing Pharma & Drug Safety Cinnamyl Alcohol Derivative for Appetite Reduction
Routine Notice Added Final

Cinnamyl Alcohol Derivative for Appetite Reduction

Favicon for changeflow.com EPO Patent Bulletin - Pharma (A61K)
Published
Detected
Email

Summary

The European Patent Office published application EP3474833A1 for Symrise AG covering a cinnamyl alcohol derivative for reducing appetite and generating satiety. The invention lists Veronika Somoza, Barbara Lieder, Katrin Geissler, Joachim Hans, Kathrin Langer, Jakob Peter Ley, and Sabine Widder as inventors. The application classifies under A61K 31/015, A61K 31/185, and A61K 31/215. Validated designated states include DE, FR, GB, IT, ES, NL, and other EPC contracting states.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The EPO published patent application EP3474833A1 for a cinnamyl alcohol derivative and its use in reducing appetite and generating the feeling of fullness. The application names Symrise AG as applicant and covers pharmaceutical compositions comprising the compound.

Pharmaceutical companies developing appetite suppression, weight management, or satiety-enhancing products should review this patent for potential freedom-to-operate concerns. Competitors in the functional food, nutritional supplement, or pharmaceutical space may need to consider licensing negotiations or design-around strategies.

What to do next

  1. Monitor for patent grant and national validation
  2. Review freedom-to-operate implications for appetite-suppression products

Archived snapshot

Apr 16, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

CINNAMYL ALCOHOL DERIVATIVE FOR USE IN REDUCING APPETITE AND FOR GENERATING THE FEELING OF BEING FULL

Publication EP3474833A1 Kind: A1 Apr 08, 2026

Applicants

Symrise AG

Inventors

SOMOZA, Veronika, LIEDER, Barbara, GEISSLER, Katrin, HANS, Joachim, LANGER, Kathrin, LEY, Jakob, Peter, WIDDER, Sabine

IPC Classifications

A61K 31/015 20060101AFI20171229BHEP A61K 31/185 20060101ALI20171229BHEP A61K 31/215 20060101ALI20171229BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 8th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3474833A1

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent application publication Pharmaceutical composition Appetite suppression method
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!